These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4061398)

  • 1. Theophylline dosage in The Harriet Lane Handbook.
    Cole CH
    Am J Dis Child; 1985 Nov; 139(11):1073. PubMed ID: 4061398
    [No Abstract]   [Full Text] [Related]  

  • 2. Theophylline doses in The Harriet Lane Handbook.
    Iafrate RP; Hendeles L; Neims A
    Am J Hosp Pharm; 1982 May; 39(5):788. PubMed ID: 7081249
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentially dangerous theophylline dose recommendations in The Harriet Lane Handbook.
    Massanari M; Hendeles L
    J Pediatr; 1985 Feb; 106(2):348-9. PubMed ID: 3968632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of poisoning in children under one year of age based on guidelines from the Swedish Pharmacologic Register on the dosage of theophylline].
    Lönnerholm G; Gebre-Medhin M
    Lakartidningen; 1983 Sep; 80(38):3397-8. PubMed ID: 6633071
    [No Abstract]   [Full Text] [Related]  

  • 5. Who was Harriet Lane?
    Swartz MK
    J Pediatr Health Care; 2013; 27(5):317. PubMed ID: 23972783
    [No Abstract]   [Full Text] [Related]  

  • 6. Criticism of FDA recommendations for theophylline dosage.
    Murphy JE; Ward ES
    N Engl J Med; 1980 Sep; 303(13):760-1. PubMed ID: 7402287
    [No Abstract]   [Full Text] [Related]  

  • 7. New FDA guidelines for theophylline dosing in infants.
    Murphy JE; Erkan NV; Fakhreddine F
    Clin Pharm; 1986 Jan; 5(1):16. PubMed ID: 3948482
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of theophylline in infants.
    FDA Drug Bull; 1985 Aug; 15(2):16-7. PubMed ID: 4054451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical study of the method in P.I. 1st Ed. for evaluation of theophylline and aminophylline].
    Vilas Sanchez V; De Bolos Capdevila J; Castillo Cofiño M
    Boll Chim Farm; 1974 Jun; 113(6):370-5. PubMed ID: 4424658
    [No Abstract]   [Full Text] [Related]  

  • 11. Concerns about the Food and Drug Administration guidelines for neonatal theophylline dosing.
    Gal P; Gilman JT
    Ther Drug Monit; 1986; 8(1):1-3. PubMed ID: 3961885
    [No Abstract]   [Full Text] [Related]  

  • 12. Individualization of dosage for oral theophylline therapy.
    Cabanas R; Peña JU; Castro-Gago M; Tojo J
    J Pediatr; 1982 Jan; 100(1):169-70. PubMed ID: 7057308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Are theophylline determinations useful to the clinician during treatment with a sustained-release form of theophylline?].
    Autret E; Lebranchu Y; Blanchard P; Nsabiyumua F; Breteau M; Grenier B; Jonville AP
    Therapie; 1990; 45(1):19-22. PubMed ID: 2343431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline pharmacokinetics in the young infant.
    Rosen JP; Danish M; Ragni MC; Saccar CL; Yaffe SJ; Lecks HI
    Pediatrics; 1979 Aug; 64(2):248-51. PubMed ID: 471616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of practical timing of dosage on theophylline blood levels in asthmatic children treated with choline theophyllinate.
    McKenzie SA; Baillie E; Godfrey S
    Arch Dis Child; 1978 Feb; 53(2):167-8. PubMed ID: 646421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline therapy. Titrating dosage requirements.
    Uden DL; Wyatt RA; Zaske DE
    Postgrad Med; 1984 Jun; 75(8):247-56. PubMed ID: 6728740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to determine theophylline dosage?].
    Droszcz W
    Pneumonol Pol; 1988 Oct; 56(10):463-6. PubMed ID: 3254509
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of the mean dose of oral theophylline in asthmatic children (author's transl)].
    Cabanas R; Peña J; Fuster M; Cortizo E; Castro-Gago M; Couselo JM; Tojo R
    An Esp Pediatr; 1982 Feb; 16(2):119-26. PubMed ID: 7081857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent decrease in population clearance of theophylline: implications for dosage.
    Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
    Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in health care resource utilization associated with extended-release theophylline.
    Schulz RM; Yates WN
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):267-72. PubMed ID: 10094217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.